STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDCX
  4. [EFFECT] Medicus Pharma Ltd. SEC Filing

[EFFECT] Medicus Pharma Ltd. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 4, 2026 9:00 A.M.
Form: S-3
CIK: 0001997296
Company Name: Medicus Pharma Ltd.
File Number: 333-293091

Source: View Original Filing on SEC EDGAR

Stock MDCX logo
Medicus Pharma Ltd

NASDAQ:MDCX

MDCX Rankings

#5985 Ranked by Market Cap
N/A Ranked by Dividends

MDCX Latest News

Feb 10, 2026
Medicus Pharma Receives FDA “Study May Proceed” Clearance For Teverelix® Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk
Jan 23, 2026
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
Jan 22, 2026
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
Jan 20, 2026
Medicus Pharma Ltd. Celebrates One Year on Nasdaq with Opening Bell Ceremony on January 22, 2026
Jan 12, 2026
Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women

MDCX Latest SEC Filings

Jan 30, 2026
[S-3] Medicus Pharma Ltd. Shelf Registration Statement
Dec 8, 2025
[8-K] Medicus Pharma Ltd. Reports Material Event
Dec 18, 2025
[Form 4] Medicus Pharma Ltd. Insider Trading Activity
Dec 18, 2025
[Form 4] Medicus Pharma Ltd. Insider Trading Activity
Dec 18, 2025
[Form 4] Medicus Pharma Ltd. Insider Trading Activity

MDCX Stock Data

24.15M
17.84M
35.91%
14.9%
1.87%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
Canada
W. CONSHOHOCKEN